Varex Imaging Updates Merger Proxy Amid Lawsuits; Regulatory Reviews Remain Pending
Published . Updated .
Varex Imaging supplemented its merger proxy disclosures following shareholder litigation and demand letters, while maintaining its recommendation to approve the Teledyne merger.Key Highlights:Original SEC Filing: Varex Imaging Corp [ VREX ] - 8-K - Oct. 22, 2026This is an
Directly affected
- VREX Varex Imaging-0.2%
Named in this report.
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Varex Imaging Updates Merger Proxy Amid Lawsuits; Regulatory Reviews Remain Pending TradingView
Source: TradingView
This story
12 out of 100
“Varex Imaging Updates Merger Proxy Amid Lawsuits; Regulatory Reviews Remain Pending” scores 12 out of 100. The score uses 1 sources.